Latest Articles

Publication Date
All News Scientific
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post

FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post

Published: Nov. 14, 2025, 3:26 p.m.
Read Full Article
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - Cancer Cell International

Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression Cancer Cell International

Published: Nov. 14, 2025, 4:25 a.m.
Read Full Article
Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 - Quiver Quantitative

Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 Quiver Quantitative

Published: Nov. 13, 2025, 9:25 p.m.
Read Full Article
Insufficient Endometrial Biopsy Increases Cancer Risk - European Medical Journal

Insufficient Endometrial Biopsy Increases Cancer Risk European Medical Journal

Published: Nov. 13, 2025, 1:03 p.m.
Read Full Article
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare

Published: Nov. 13, 2025, 6:17 a.m.
Read Full Article
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어

Published: Nov. 13, 2025, 5:50 a.m.
Read Full Article
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer - CancerNetwork

FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer CancerNetwork

Published: Nov. 12, 2025, 7:12 p.m.
Read Full Article
FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma - Targeted Oncology

FDA Clears New CDx for Pembrolizumab/Lenvatinib in Endometrial Carcinoma Targeted Oncology

Published: Nov. 12, 2025, 7:08 p.m.
Read Full Article
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer - University of Miami

Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer University of Miami

Published: Nov. 12, 2025, 1:59 p.m.
Read Full Article
The efficacy of adjuvant therapies in improving endometrial function of women undergoing assisted reproductive technology: a systematic review and network meta-analysis - BMC Pregnancy and Childbirth

The efficacy of adjuvant therapies in improving endometrial function of women undergoing assisted reproductive technology: a systematic review and network meta-analysis BMC Pregnancy and Childbirth

Published: Nov. 12, 2025, 1:46 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!